Luina Bio, XING to bring in fast SARS-CoV-2 diagnostic kit
Singapore, July 13 -- Australia based Luina Bio is pleased to announce they have been selected to partner with XING Technologies (Brisbane) to co-develop and manufacture a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) diagnostic kit.
The COVID-19 detection technology is based on a temperature- stable molecule utilising Xing patented technology.
XING is looking to fast-track the development and regulatory approval of the diagnostic kit to meet customer needs in USA, Europe and the pan-Asian region. These customers have been looking for a fast and accurate point-of-care antigen test as a superior alternate to existing serology tests which measure immune response. The test being developed by XING and its partners is focussed...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.